301 495

Cited 4 times in

Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma

DC FieldValueLanguage
dc.contributor.author김영재-
dc.contributor.author이용강-
dc.contributor.author임승택-
dc.contributor.author정원재-
dc.contributor.author최아라-
dc.contributor.author최혜진-
dc.contributor.author한정우-
dc.date.accessioned2014-12-18T09:43:58Z-
dc.date.available2014-12-18T09:43:58Z-
dc.date.issued2013-
dc.identifier.issn1598-2998-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/88722-
dc.description.abstractHumoral hypercalcemia of malignancy (HHM) is rarely associated with cholangiocarcinoma (CC), and represents dismal prognosis. A 63-year-old male was admitted for evaluation of an intrahepatic mass. He was diagnosed with HHM associated with locally advanced CC. As the tumor responded to the concurrent chemoradiotherapy with capecitabine and cisplatin, serum calcium level was normalized. However, according to the disease progression, he suffered recurrence of HHM and he expired approximately one year after initial diagnosis. A 68-year-old male who presented with abdominal pain was diagnosed with metastatic CC. After the eighth cycle of gemcitabine and cisplatin, progression of the disease was found with HHM. He was treated with the best supportive care, until his demise approximately one month after the diagnosis of HHM. We report on two cases of HHM associated with CC that demonstrate strong correlation between hypercalcemia and disease burden.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.relation.isPartOfCANCER RESEARCH AND TREATMENT-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleTwo Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorSeungtaek Lim-
dc.contributor.googleauthorJungwoo Han-
dc.contributor.googleauthorKyeong Hye Park-
dc.contributor.googleauthorWon Jai Jung-
dc.contributor.googleauthorYong Kang Lee-
dc.contributor.googleauthorAra Choi-
dc.contributor.googleauthorYoung Jae Kim-
dc.contributor.googleauthorJong-Chan Lee-
dc.contributor.googleauthorHye Jin Choi-
dc.identifier.doi10.4143/crt.2013.45.2.145-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02973-
dc.contributor.localIdA03380-
dc.contributor.localIdA03677-
dc.contributor.localIdA04104-
dc.contributor.localIdA04219-
dc.contributor.localIdA04324-
dc.contributor.localIdA00722-
dc.relation.journalcodeJ00453-
dc.identifier.eissn2005-9256-
dc.identifier.pmid23864848-
dc.subject.keywordCholangiocarcinoma-
dc.subject.keywordHypercalcemia-
dc.subject.keywordParathyroid hormone-related protein-
dc.contributor.alternativeNameKim, Young Jae-
dc.contributor.alternativeNameLee, Yong Kang-
dc.contributor.alternativeNameLim, Seung Taek-
dc.contributor.alternativeNameJung, Won Jai-
dc.contributor.alternativeNameChoi, A Ra-
dc.contributor.alternativeNameChoi, Hye Jin-
dc.contributor.alternativeNameHan, Jung Woo-
dc.contributor.affiliatedAuthorLee, Yong Kang-
dc.contributor.affiliatedAuthorLim, Seung Taek-
dc.contributor.affiliatedAuthorJung, Won Jai-
dc.contributor.affiliatedAuthorChoi, A Ra-
dc.contributor.affiliatedAuthorChoi, Hye Jin-
dc.contributor.affiliatedAuthorHan, Jung Woo-
dc.contributor.affiliatedAuthorKim, Young Jae-
dc.rights.accessRightsfree-
dc.citation.volume45-
dc.citation.number2-
dc.citation.startPage145-
dc.citation.endPage149-
dc.identifier.bibliographicCitationCANCER RESEARCH AND TREATMENT, Vol.45(2) : 145-149, 2013-
dc.identifier.rimsid33572-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.